What is thalassemia and how many people in India are affected?

Thalassemia is a genetic blood disorder affecting haemoglobin production. In India, nearly 45 million people are carriers, with 15,000 children born annually with thalassemia major.

How can India prevent new cases of thalassemia major?

Antenatal screening of pregnant women and their partners is the most effective method to prevent new cases of thalassemia major.

Which Indian districts are leading in thalassemia prevention?

Mahbubnagar district in Telangana is the first to ensure 100% prenatal screening for pregnant women.

Home / Health / A Thalassemia-Free Future? India's Bold Health Goal

A Thalassemia-Free Future? India's Bold Health Goal

13 Jan

•

Summary

Nearly 45 million people in India are thalassemia carriers.
Annual births of children with thalassemia major exceed 15,000.
Prenatal screening is highlighted as the most effective prevention method.

A Thalassemia-Free Future? India's Bold Health Goal

India faces a critical juncture in public health, with an estimated 45 million individuals as thalassemia carriers. Annually, approximately 15,000 children are born with thalassemia major, a preventable genetic blood disorder impacting hemoglobin production. The condition necessitates lifelong transfusions and chelation therapy, with bone marrow transplants being a costly option.

International examples from Cyprus and Iran show that widespread screening and awareness campaigns can drastically reduce thalassemia cases. India aims to replicate and surpass these successes, with antenatal screening being a primary strategy. This involves screening pregnant women and their partners to identify at-risk pairs early, empowering them to prevent new cases.

Positive strides are being made, with Mahbubnagar district in Telangana leading in 100% prenatal screening. Other states are adopting similar initiatives. The National Health Mission provides a framework for enhancing antenatal screening, genetic counseling, and public awareness, paving the way for a thalassemia-free future within five years.